Advanced in Menorrhagia

Dr. Ronald T. Ackerman

Obstetrics and Gynecology
Raulerson Gyn LLC
12953 Palms W Dr, Suite 101, 
Loxahatchee, FL 
Accepting New Patients
Advanced in Menorrhagia
Raulerson Gyn LLC
12953 Palms W Dr, Suite 101, 
Loxahatchee, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Ronald Ackerman is an Obstetrics and Gynecologist in Loxahatchee, Florida. Dr. Ackerman is rated as an Advanced provider by MediFind in the treatment of Menorrhagia. His top areas of expertise are Trichomoniasis, Bowenoid Papulosis, Vulvovaginitis, and Menorrhagia. Dr. Ackerman is currently accepting new patients.

His clinical research consists of co-authoring 12 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Menorrhagia.

Specialties
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in FL
Languages Spoken
English
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

RAULERSON GYN LLC
12953 Palms W Dr, Suite 101, Loxahatchee, FL 33470
Other Locations
RAULERSON GYN LLC
603 Village Blvd, Suite 201, West Palm Beach, FL 33409

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine (SARS-CoV-2 rS) With Matrix-M1™ Adjuvant in Adult Participants ≥ 18 Years With a Pediatric Expansion in Adolescents (12 to < 18 Years)
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Biological, Other
Study Drug: SARS-CoV-2 rS/Matrix-M1 Adjuvant
Study Phase: Phase 3
A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™-5PSP for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Cervix
A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™-5PSP for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the Cervix
Enrollment Status: Completed
Publish Date: July 27, 2023
Intervention Type: Biological, Device
Study Drug: VGX-3100
Study Phase: Phase 3
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Drug
Study Drugs: Gepotidacin, Nitrofurantoin
Study Phase: Phase 3
A Phase III, Randomized, Open-label, Active Vaccine-controlled Crossover Study to Evaluate the Reactogenicity, Safety and Immune Response of Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Girls From 9 to 17 Years of Age, and in Non-pregnant Adult Women From 18 to 49 Years of Age
A Phase III, Randomized, Open-label, Active Vaccine-controlled Crossover Study to Evaluate the Reactogenicity, Safety and Immune Response of Unadjuvanted RSV Maternal Vaccine in Healthy Non-pregnant Girls From 9 to 17 Years of Age, and in Non-pregnant Adult Women From 18 to 49 Years of Age
Enrollment Status: Completed
Publish Date: April 07, 2023
Intervention Type: Combination product
Study Phase: Phase 3
A Phase 3 Multi-Center, Double-Blind, Placebo-Controlled, Randomized Study of DARE-BV1 in the Treatment of Bacterial Vaginosis
A Phase 3 Multi-Center, Double-Blind, Placebo-Controlled, Randomized Study of DARE-BV1 in the Treatment of Bacterial Vaginosis
Enrollment Status: Completed
Publish Date: December 08, 2022
Intervention Type: Drug
Study Phase: Phase 3
Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 IgG Antibody Test in Fingerstick Whole Blood
Clinical Evaluation of a Point-of-Care (POC), SARS-CoV-2 IgG Antibody Test in Fingerstick Whole Blood
Enrollment Status: Completed
Publish Date: June 18, 2021
Intervention Type: Diagnostic test
Phase 2B Double-blind Placebo-controlled Efficacy Trial of EVO100 (Previously Known as Amphora ® Gel) for the Prevention of Acquisition of Urogenital Chlamydia Trachomatis Infection
Phase 2B Double-blind Placebo-controlled Efficacy Trial of EVO100 (Previously Known as Amphora ® Gel) for the Prevention of Acquisition of Urogenital Chlamydia Trachomatis Infection
Enrollment Status: Completed
Publish Date: August 12, 2020
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety
Solubilized Metronidazole And/oR Terconazole Gels Intra-Vaginal Efficacy and Safety
Enrollment Status: Completed
Publish Date: August 04, 2020
Intervention Type: Drug
Study Phase: Phase 3
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Phase 2a Double-Blind, Randomized, Parallel Group, Dose-Ranging Study to Assess the Safety and Efficacy of Three Doses of TVGV-1 Vaccine Compared to Its Adjuvant, GPI-0100, in Subjects With Histologically Confirmed HPV Induced Cervical HSIL
Enrollment Status: Unknown
Publish Date: October 25, 2017
Intervention Type: Biological
Study Drugs: TVGV-1, GPI-0100
Study Phase: Phase 2
View 8 Less Clinical Trials

12 Total Publications

Evaluation of Cepheid Xpert Xpress CoV-2/Flu/RSV plus for nasal and nasopharyngeal specimens tested in CLIA-accredited and CLIA-waived settings.
Evaluation of Cepheid Xpert Xpress CoV-2/Flu/RSV plus for nasal and nasopharyngeal specimens tested in CLIA-accredited and CLIA-waived settings.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: April 22, 2025
Similar Doctors
Advanced in Menorrhagia
Dr. Eliana Bejarano
Obstetrics and Gynecology
Advanced in Menorrhagia
Dr. Eliana Bejarano
Obstetrics and Gynecology

Soma Medical Center PA 9

3325 Forest Hill Blvd, Suite B, 
West Palm Beach, FL 
 (9.8 miles away)
561-227-2772
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Eliana Bejarano is an Obstetrics and Gynecologist in West Palm Beach, Florida. Dr. Bejarano is rated as an Advanced provider by MediFind in the treatment of Menorrhagia. Her top areas of expertise are Menorrhagia, Menopause, Pelvic Inflammatory Disease, Vulvovaginitis, and Intrauterine Device Insertion. Dr. Bejarano is currently accepting new patients.

Advanced in Menorrhagia
Dr. Seth J. Herbst
Obstetrics and Gynecology
Advanced in Menorrhagia
Dr. Seth J. Herbst
Obstetrics and Gynecology
1395 S State Rd, 7 Suite 340, 
Wellington, FL 
 (3.4 miles away)
Languages Spoken:
English, Russian, Spanish
See accepted insurances
Accepting New Patients

Seth Herbst is an Obstetrics and Gynecologist in Wellington, Florida. Dr. Herbst is rated as an Advanced provider by MediFind in the treatment of Menorrhagia. His top areas of expertise are Menopause, Fibrocystic Breast Disease, Breast Infection, Hormone Replacement Therapy (HRT), and Hysterectomy. Dr. Herbst is currently accepting new patients.

Advanced in Menorrhagia
Dr. Neil A. Salas
Obstetrics and Gynecology
Advanced in Menorrhagia
Dr. Neil A. Salas
Obstetrics and Gynecology
7700 W Sunrise Blvd, 
Plantation, FL 
 (37.0 miles away)
Languages Spoken:
English, Arabic, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Neil Salas is an Obstetrics and Gynecologist in Plantation, Florida. Dr. Salas is rated as an Advanced provider by MediFind in the treatment of Menorrhagia. His top areas of expertise are Menorrhagia, Angiomyoma, Vaginal Cysts, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy. Dr. Salas is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ackerman's expertise for a condition
ConditionClose
      View All 21 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile